On-Site Cardiovascular Wellness Screening
Pulse 4 Pulse
A 20-minute, non-invasive assessment that catches chronic disease before it becomes catastrophic.
Pulse 4 Pulse (P4P) pioneers proactive diagnostic cardiovascular wellness testing — assessing both the macrovascular and microvascular systems. The mission is simple: shift the paradigm from reactive to proactive healthcare, empowering individuals with insight into their cardiovascular health at the earliest, most treatable stages.
Through a turnkey, on-site testing model, P4P partners with physician practices, employers, and health-conscious organizations to identify hidden chronic disease before it becomes catastrophic — providing the equipment, the certified medical staff, and real-time results.
The Hidden Health Crisis
The Gap in Standard Care
The current standard of care is designed to identify late-stage macrovascular disease — addressing only about 15% of the vascular system. Early microvascular dysfunction, the foundation of vascular disease, largely goes undetected until it results in a serious or catastrophic clinical event. P4P adds the missing 85%, screening both micro- and macrovascular systems for a 100% protocol.
The 3-Test Protocol
1. Autonomic Nervous System (ANS)
- Measures heart-rate variability and beat-to-beat blood pressure during deep-breathing, head-tilt, and Valsalva maneuver tests to identify nervous-system disease and endothelial dysfunction.
2. Sudomotor Test
- Stimulates sweat glands with low voltage through a glass plate to detect neuropathy and early vascular disease risk — identifying patients before symptoms appear.
3. Ankle-Brachial Index (ABI)
- Measures the ratio of upper- and lower-body blood pressure to detect peripheral vascular disease and assess circulatory health at the macro level.
How It Works
- P4P provides all testing equipment and a certified medical assistant on-site.
- The patient completes a brief intake form to confirm eligibility.
- The technician conducts the 20-minute, non-invasive cardiovascular assessment.
- Real-time results and clinical recommendations are delivered immediately to the individual.
- About 60% of adult patients qualify based on commonly encountered risk criteria — one of the highest-yield preventative services available.
Conditions Identified
Cardiovascular & Vascular
- Peripheral Artery Disease (PAD)
- Coronary Artery Disease (CAD)
- Hypertension / elevated blood pressure
- Endothelial dysfunction
- Early-stage microvascular disease
Metabolic & Neurological
- Diabetes (Type 1 & Type 2)
- Cardiac autonomic neuropathy (CAN)
- Peripheral neuropathy
- Autonomic nervous system disorders
- Pre-diabetic / at-risk conditions
The Financial Case — 500-Person Organization
| Financial Summary | Amount |
|---|---|
| P4P Assessment Investment (300 members × $250) | $125,000 |
| Estimated Undetected Disease Cost Exposure | $1,866,100 |
| Estimated Absenteeism Cost | $150,000+ |
| Estimated Presenteeism / Productivity Loss | $100,000+ |
| Estimated Total Cost Avoided (Conservative) | $2,116,100+ |
| Estimated ROI on P4P Investment | ~17:1 |
This Is Not a Wellness Perk — It Is Risk Management
The most expensive healthcare decision an organization can make is choosing not to act. Undetected chronic disease eventually surfaces as an emergency-room visit, a disability claim, or a premature death. P4P gives leaders the opportunity to intervene while intervention is still affordable — delivering both measurable ROI and life-changing insight to members.
Continue the Conversation
Walker & Meier Consulting can walk your command staff and wellness officers through implementation, relevance, and agency impact.